What Is Medication-Assisted Treatment (MAT)?

Medication-assisted treatment — commonly called MAT — is one of the most effective and most misunderstood approaches to treating addiction. According to SAMHSA (the Substance Abuse and Mental Health Services Administration), MAT is the gold standard for opioid use disorder treatment. Yet stigma, misinformation, and gaps in access keep many people from getting it.

This guide explains exactly what MAT is, how the medications work, who it's right for, and how to find a program.

What Is MAT?

Medication-assisted treatment combines FDA-approved medications with counseling and behavioral therapies to treat substance use disorders — primarily opioid use disorder (OUD) and alcohol use disorder (AUD).

The medications reduce cravings, block the effects of opioids, and prevent withdrawal — allowing people to stabilize, engage in therapy, and rebuild their lives. MAT is not a standalone fix; the counseling component is essential. But the combination has been proven in hundreds of clinical trials to outperform either medication or therapy alone.

MAT Medications for Opioid Use Disorder

There are three FDA-approved medications for opioid use disorder:

1. Buprenorphine (Suboxone, Subutex, Sublocade)

Buprenorphine is a partial opioid agonist — it activates the same receptors as opioids but only partially, which reduces cravings and withdrawal without producing a full "high." It also has a ceiling effect that limits the risk of overdose from the medication itself.

Suboxone combines buprenorphine with naloxone (an opioid blocker) to deter misuse. It's taken as a dissolvable film under the tongue. Certified physicians can prescribe buprenorphine in office settings, making it accessible compared to methadone.

Sublocade is a monthly injectable form of buprenorphine — useful for people who struggle with daily dosing adherence.

2. Methadone

Methadone is a full opioid agonist that eliminates withdrawal and cravings when taken at the correct dose. It must be dispensed daily at a federally licensed opioid treatment program (OTP) — at least initially. Long-term stable patients may receive take-home doses.

Methadone has decades of research behind it and is often the preferred option for people with severe, long-term opioid use disorder or those who haven't responded to buprenorphine. The daily clinic requirement can be a barrier, but it also provides structure and daily touchpoints with healthcare staff.

3. Naltrexone (Vivitrol)

Naltrexone is an opioid antagonist — it completely blocks opioid receptors, making opioids ineffective if taken while on it. Vivitrol is an extended-release injectable given once monthly.

Unlike methadone and buprenorphine, naltrexone has zero abuse potential and is not a controlled substance. However, it requires a full detox (7-10 days opioid-free) before starting, and adherence can be challenging. It's a strong option for people who prefer not to take an opioid-based medication or who face certain professional or legal constraints.

MAT Medications for Alcohol Use Disorder

Three medications are FDA-approved for alcohol use disorder:

• Naltrexone (oral or Vivitrol) — reduces cravings and the rewarding effects of alcohol
• Acamprosate (Campral) — reduces the physical and emotional discomfort of post-acute withdrawal and cravings during early sobriety
• Disulfiram (Antabuse) — causes an unpleasant physical reaction when alcohol is consumed, acting as a deterrent

These are often used alongside therapy programs like cognitive behavioral therapy (CBT), motivational interviewing, or 12-step facilitation.

The "Trading One Addiction for Another" Myth

This is one of the most persistent and damaging misconceptions about MAT — particularly regarding methadone and buprenorphine. The reality:

• Physical dependence on a medication is not the same as addiction
• People on stable MAT doses function normally — they work, parent, drive, and engage in life
• The alternative — untreated opioid use disorder — carries a 2–6% annual overdose mortality rate
• SAMHSA, NIDA, the American Society of Addiction Medicine (ASAM), and every major medical organization endorse MAT
• Withholding MAT is now considered a form of medical negligence in many contexts

If someone tells you that using medication to treat addiction "isn't real recovery," they're working from stigma, not science.

Who Is MAT Right For?

MAT is appropriate for most people with moderate to severe opioid use disorder and many with alcohol use disorder. It's particularly important for:

• People with a history of overdose
• Those who have relapsed after non-MAT treatment
• People with co-occurring chronic pain who were using opioids for pain management
• Pregnant women with OUD (buprenorphine and methadone are both safer than active opioid use during pregnancy)
• Anyone with severe physical dependence where abrupt cessation would be dangerous

A clinical assessment will determine which medication and delivery model is the best fit. The Recovery Source can help match you with MAT-integrated programs based on your specific situation and insurance.

How to Find a MAT Program

MAT is available at:

• Opioid treatment programs (OTPs) — offer methadone + counseling
• Office-based opioid treatment (OBOT) — buprenorphine through a certified physician
• Residential treatment programs with MAT integration
• FQHCs (community health centers) — often offer sliding-scale or free MAT
• Telehealth providers — buprenorphine can now be prescribed via video visit

Insurance coverage for MAT is strong under current federal law. Most commercial insurers, Medicaid, and Medicare cover MAT medications and associated counseling.

Call (754) 234-1450 and we'll identify programs in your area, verify your insurance, and help coordinate admission. There's no cost to you.